Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662. (Q43736424)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662. |
scientific article |
Statements
1 reference
Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662. (English)
1 reference
1 reference
Cancer and Leukemia Group B
1 reference
C T Cirrincione
1 reference
D F Hayes
1 reference
H Yamauchi
1 reference
G Broadwater
1 reference
S P Rodrigue
1 reference
D A Berry
1 reference
J Younger
1 reference
L L Panasci
1 reference
F Millard
1 reference
D B Duggan
1 reference
I C Henderson
1 reference
1 September 2001
1 reference
1 reference
7
1 reference
9
1 reference
2703-2711
1 reference
Identifiers
1 reference